Free tools, ads, and affiliate links help keep StockifyX free.

Disclosure Brokers

Vertex Pharmaceuticals (VRTX)

Price Chart

Candlestick · Volume · EMA · BB · VWAP · MACD · RSI · Drawing Tools

Last

—

1D CHG

—

RSI(14)

Loading chart…

Candlestick chart with volume — data via Yahoo Finance · For educational use only

Dividends

Options Chain

Delayed data

News Sentiment

positiveavg 0.605↑ · 0→ · 0↓

Vertex Pharmaceuticals Submits Povetacicept For The Treatment Of Immunoglobulin A Nephropathy For Accelerated Approval From The FDA; Expects FDA Review To Be Accelerated From Usual 10-Month Review Period To 6-Month Review
Benzinga·Mar 31, 2026positive
I Expect Crispr Therapeutics To Break Out As 2026 Revenue Exceeds Expectations
Crispr Therapeutics AG looks set for 2026 revenue inflection as Casgevy ramps; strong efficacy, undervalued shares, robust pipeline. Click for this CRSP update.
SeekingAlpha·Mar 31, 2026positive
If You Invested $1000 In Vertex Pharmaceuticals Stock 15 Years Ago, You Would Have This Much Today

Benzinga·Mar 30, 2026positive
Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day
MarketWatch·Mar 30, 2026positive
1 Cash-Producing Stock with Promising Prospects and 2 We Turn Down
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Yahoo·Mar 30, 2026positive

Sentiment scored by an AI model on article tone. Not investment advice.

Paper Trade

Practice Trading VRTX

Trade risk-free with $10,000 virtual cash.

Type

Stock

Risk

Zero

Cash

$10K

Mode

Live data

Buy VRTX (Paper)Sell VRTX (Paper)

Paper trading only — no real money involved

Ready to Trade Vertex Pharmaceuticals?

Open a real trading account with a regulated broker:

View Broker Options →

Practice Trading VRTX

PAPER ONLY

Virtual Balance

$10,000.00 (simulated)

See the VRTX 2026 forecast

Wall Street consensus price target, implied upside, and analyst breakdown.

View VRTX Forecast →

Related Analysis

More assets in the same theme

Explore more market pages for VRTX related opportunities.

VRTX Frequently Asked Questions

What is the current VRTX stock price?+

Vertex Pharmaceuticals (VRTX) is currently trading at live market price. See the live chart on this page for the latest move. Prices update live throughout market hours on this page.

Is VRTX a buy, sell, or hold?+

Wall Street analyst consensus, AI signals, and recent news sentiment for VRTX are shown above. StockifyX surfaces the data; the decision is yours — try the call risk-free with paper trading first.

When does Vertex Pharmaceuticals report earnings?+

The next VRTX earnings date is shown in the Earnings section above, along with the historical EPS surprise track record.

Does VRTX pay a dividend?+

Dividend yield, payout ratio, and ex-dividend date for VRTX are listed in the Dividends card on this page when applicable.

How can I trade VRTX risk-free?+

StockifyX gives you $10,000 in virtual cash to paper-trade VRTX at real market prices — no real money required. Click "Paper Trade" above to get started.

Where can I find VRTX news and analyst ratings?+

The latest VRTX headlines with sentiment scoring, plus the full Wall Street analyst rating breakdown, are listed further down this page.

Buy VRTX Stock →